Active Shortage Powder, For Solution Oncology
Streptozocin Powder, For Sol · 1,522 days since initial FDA posting
FDA lists Streptozocin Powder, For Sol as Active Shortage (Teva Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Streptozocin Powder, For Solution: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Streptozocin Powder, For Solution
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Powder, For Solution
- Presentation
- Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)
- Package NDC
- 0703-4636-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jul 12, 2022
- Last Updated
- Mar 2, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: TBD
Nearby, Other Streptozocin Shortage Records
FDA reason on file: Estimated recovery: TBD. General shortage guidance lives on the tracker hub.